Faculty Opinions recommendation of Initial testing (stage 1) of the PARP inhibitor BMN 673 by the pediatric preclinical testing program: PALB2 mutation predicts exceptional in vivo response to BMN 673.

2016 ◽  
Author(s):  
Stephen Lessnick
Keyword(s):  
Parp Inhibitor ◽  
Preclinical Testing ◽  
Testing Program ◽  
Initial Testing ◽  
Testing Stage ◽  
Palb2 Mutation ◽  
Stage 1

scholarly journals Initial testing (stage 1) by the pediatric preclinical testing program of RO4929097, a γ-secretase inhibitor targeting notch signaling

2011 ◽  
Vol 58 (5) ◽  
pp. 815-818 ◽  
Author(s):  
E. Anders Kolb ◽  
Richard Gorlick ◽  
Stephen T. Keir ◽  
John M. Maris ◽  
Richard Lock ◽  
...  
Keyword(s):  
Notch Signaling ◽  
Preclinical Testing ◽  
Testing Program ◽  
Initial Testing ◽  
Secretase Inhibitor ◽  
Testing Stage ◽  
Stage 1

scholarly journals Initial testing (stage 1) of glembatumumab vedotin (CDX-011) by the pediatric preclinical testing program

2014 ◽  
Vol 61 (10) ◽  
pp. 1816-1821 ◽  
Author(s):  
E. Anders Kolb ◽  
Richard Gorlick ◽  
Catherine A. Billups ◽  
Thomas Hawthorne ◽  
Raushan T. Kurmasheva ◽  
...  
Keyword(s):  
Preclinical Testing ◽  
Testing Program ◽  
Initial Testing ◽  
Testing Stage ◽  
Stage 1

scholarly journals Initial testing (stage 1) of the Akt inhibitor GSK690693 by the pediatric preclinical testing program

2010 ◽  
Vol 55 (7) ◽  
pp. 1329-1337 ◽  
Author(s):  
Hernan Carol ◽  
Christopher L. Morton ◽  
Richard Gorlick ◽  
E. Anders Kolb ◽  
Stephen T. Keir ◽  
...  
Keyword(s):  
Akt Inhibitor ◽  
Preclinical Testing ◽  
Testing Program ◽  
Initial Testing ◽  
Testing Stage ◽  
Stage 1

scholarly journals Initial testing (Stage 1) of AT13387, an HSP90 inhibitor, by the pediatric preclinical testing program

2011 ◽  
Vol 59 (1) ◽  
pp. 185-188 ◽  
Author(s):  
Min H. Kang ◽  
C. Patrick Reynolds ◽  
Peter J. Houghton ◽  
Denise Alexander ◽  
Christopher L. Morton ◽  
...  
Keyword(s):  
Hsp90 Inhibitor ◽  
Preclinical Testing ◽  
Testing Program ◽  
Initial Testing ◽  
Testing Stage ◽  
Stage 1

Abstract A137: Initial testing (Stage 1) of EPZ-6438 (tazemetostat), a novel EZH2 inhibitor, by the pediatric preclinical testing program (PPTP)

2015 ◽  
Author(s):  
Raushan Kurmasheva ◽  
Kat Cosmopoulos ◽  
Melissa Sammons ◽  
Edward Favours ◽  
Jianwrong Wu ◽  
...  
Keyword(s):  
Preclinical Testing ◽  
Testing Program ◽  
Initial Testing ◽  
Testing Stage ◽  
Stage 1

scholarly journals Initial testing (Stage 1) of the antibody-maytansinoid conjugate, IMGN901 (Lorvotuzumab mertansine), by the pediatric preclinical testing program

2013 ◽  
Vol 60 (11) ◽  
pp. 1860-1867 ◽  
Author(s):  
Andrew C. Wood ◽  
John M. Maris ◽  
Richard Gorlick ◽  
E. Anders Kolb ◽  
Stephen T. Keir ◽  
...  
Keyword(s):  
Preclinical Testing ◽  
Testing Program ◽  
Initial Testing ◽  
Testing Stage ◽  
Stage 1

scholarly journals Initial testing (stage 1) of the mTOR kinase inhibitor AZD8055 by the pediatric preclinical testing program

2011 ◽  
Vol 58 (2) ◽  
pp. 191-199 ◽  
Author(s):  
Peter J. Houghton ◽  
Richard Gorlick ◽  
E. Anders Kolb ◽  
Richard Lock ◽  
Hernan Carol ◽  
...  
Keyword(s):  
Kinase Inhibitor ◽  
Preclinical Testing ◽  
Testing Program ◽  
Initial Testing ◽  
Mtor Kinase ◽  
Testing Stage ◽  
Stage 1

scholarly journals Initial testing (stage 1) of the anti-microtubule agents cabazitaxel and docetaxel, by the Pediatric Preclinical Testing Program

2015 ◽  
Vol 62 (11) ◽  
pp. 1897-1905 ◽  
Author(s):  
C. Patrick Reynolds ◽  
Min H. Kang ◽  
John M. Maris ◽  
E. Anders Kolb ◽  
Richard Gorlick ◽  
...  
Keyword(s):  
Preclinical Testing ◽  
Testing Program ◽  
Initial Testing ◽  
Testing Stage ◽  
Stage 1

scholarly journals Initial testing (stage 1) of SGI-1776, a PIM1 kinase inhibitor, by the pediatric preclinical testing program

2011 ◽  
Vol 59 (4) ◽  
pp. 749-752 ◽  
Author(s):  
Vandana Batra ◽  
John M. Maris ◽  
Min H. Kang ◽  
C. Patrick Reynolds ◽  
Peter J. Houghton ◽  
...  
Keyword(s):  
Kinase Inhibitor ◽  
Preclinical Testing ◽  
Testing Program ◽  
Initial Testing ◽  
Pim1 Kinase ◽  
Testing Stage ◽  
Stage 1

scholarly journals Initial testing (stage 1) of the histone deacetylase inhibitor, quisinostat (JNJ-26481585), by the Pediatric Preclinical Testing Program

2013 ◽  
Vol 61 (2) ◽  
pp. 245-252 ◽  
Author(s):  
Hernan Carol ◽  
Richard Gorlick ◽  
E. Anders Kolb ◽  
Christopher L. Morton ◽  
Donya Moradi Manesh ◽  
...  
Keyword(s):  
Histone Deacetylase ◽  
Histone Deacetylase Inhibitor ◽  
Preclinical Testing ◽  
Testing Program ◽  
Initial Testing ◽  
Deacetylase Inhibitor ◽  
Testing Stage ◽  
Stage 1
Sign in / Sign up

Export Citation Format

Share Document